NEW YORK (Reuters) - A key safety trial of an experimental Ebola vaccine manufactured by GlaxoSmithKline
An additional 10 volunteers will receive the vaccine in coming days.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!